Berkshire Hathaway to purchase Lubrizol for $9 billion

Chemical company Lubrizol fits typical Berkshire Hathaway acquisition: predictable case flow and low price-to-earnings ratio.

  • close
    Billionaire financier and Berkshire Hathaway Chief Executive Warren Buffett attends the Berkshire Hathaway Annual Shareholders meeting in Omaha, Neb., in this file photo taken May 2, 2009. On Monday, Berkshire Hathaway announced it had bought Lubrizol, a chemical company.
    View Caption
  • About video ads
    View Caption
of

By David Faber, CNBC anchor and reporter

Berkshire Hathaway has agreed to purchase chemical company Lubrizol in a $9 billion cash deal worth $135 per LZ share, the two companies said Monday. The price, a roughly 28 percent premium to Lubrizol's close on Friday is also about 18 percent above the stock's all time high.

The company fits the typical profile favored by Warren Buffett in his purchases. It has fairly predictable cash flows and a high return on equity. The purchase price represents roughly 7.6 times Lubrizol's EBITDA.

Talks between the two companies began only a few weeks ago and culminated quickly in a deal that represents one of the larger acquisitions undertaken by Berkshire.

Buffett, in his recent shareholder letter, said he was actively pursuing acquisition targets to use some of Berkshire's cash.

Boards of both companies agreed to the deal over the weekend.

Share this story:

We want to hear, did we miss an angle we should have covered? Should we come back to this topic? Or just give us a rating for this story. We want to hear from you.

Loading...

Loading...

Loading...

Save for later

Save
Cancel

Saved ( of items)

This item has been saved to read later from any device.
Access saved items through your user name at the top of the page.

View Saved Items

OK

Failed to save

You reached the limit of 20 saved items.
Please visit following link to manage you saved items.

View Saved Items

OK

Failed to save

You have already saved this item.

View Saved Items

OK